首页 | 本学科首页   官方微博 | 高级检索  
检索        


Impact of systemic steroids combined with immunosuppressive treatment on glaucomatous features in patients with systemic lupus erythematosus
Authors:Marta P Wi&#x;cek  Danuta Bobrowska&#x;Snarska  Marek Brzosko  Wojciech Lubi&#x;ski  Monika Modrzejewska
Institution:First Department of Ophthalmology, Pomeranian Medical University, Szczecin 70-111, Poland; Institute of Physics, University of Szczecin, Szczecin 70-451, Poland,Department of Rheumatology, Internal Medicine and Geriatrics, Pomeranian Medical University, Szczecin 71-252, Poland,Department of Rheumatology, Internal Medicine and Geriatrics, Pomeranian Medical University, Szczecin 71-252, Poland,Second Department of Ophthalmology, Pomeranian Medical University, Szczecin 70-111, Poland and Second Department of Ophthalmology, Pomeranian Medical University, Szczecin 70-111, Poland
Abstract:AIM: To evaluate the incidence of increased intraocular pressure (IOP) and glaucomatous changes in systemic lupus erythematosus (SLE) patients in comparison with systemic steroids and immunosuppressive treatment. METHODS: Sixty-two women with SLE were divided into two groups: treated (n=47, 94 eyes) and not treated (n=15, 30 eyes) with systemic glucocorticosteroids (GC; GC-free). Twenty-one individuals in GC group were treated with immunosuppressive agents (immunomodulating and biologic). The visual acuity and IOP with ocular pulsatile amplitude (OPA) measurements, as well as scanning laser polarimetry (GDx) with nerve fiber index (NFI) measurement, spectral domain optical coherence tomography (SD-OCT) of the optic disk with retinal nerve fiber layer (RNFL) analysis and the macular region with ganglion cell analysis (GCA) were performed.  RESULTS: Mean IOP values in group with combined GC and immunosuppressive therapy was 15.8±2.56 mm Hg and was significantly lower than in individuals with exclusive GC treatment (17.63±4.38 mm Hg, P=0.043). Contrary, no differences in mean IOP values between GC-free group and individuals treated with combined GC and immunosuppressive therapy were detected (P=0.563). Similarly, mean IOP in GC was 17.14±3.94 mm Hg and in GC-free patients was equal to 16.67±3.45 mm Hg (P=0.671). According to treatment regimen no statistical differences in optic disk SD-OCT for RNFL thickness, RNFL symmetry, cupping volume and the C/D ratio were observed. Similarly, no statistical differences for the mean and minimal ganglion cell layer (GCL) thickness measured in macular SD-OCT or NFI in GDx were detected. CONCLUSION: Combined immunosuppressive and systemic GC therapy in SLE patients may lower the risk of iatrogenic ocular hypertension. No relationship between treatment regimen and glaucomatous damage of optic nerve fibers in analyzed groups with SLE is detected.
Keywords:immunosuppression  ocular hypertension  steroid induced glaucoma  steroid therapy  systemic lupus erythematosus
本文献已被 维普 等数据库收录!
点击此处可从《国际眼科杂志(英文版)》浏览原始摘要信息
点击此处可从《国际眼科杂志(英文版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号